Pathogen News and Research

RSS

Accelr8 expands development plan for BACcel rapid diagnostic test

Accelr8 Technology Corporation announced that it successfully completed two technical feasibility studies for test methods that expand its BACcel rapid diagnostic test library and automation capabilities.

23 Nov 2011

Novel antibacterial protein could prevent or treat E. coli O157:H7-induced food-borne infections

A novel antibacterial protein targeted against E. coli O157:H7 may offer a way to prevent or treat serious food-borne bacterial infections, as demonstrated in a study published in the December issue of Antimicrobial Agents and Chemotherapy.

21 Nov 2011

Princeton acquires Tru-D SmartUVC Room Decontamination System to improve patient care

In early September, Princeton Community Hospital added the Tru-D SmartUVC™ Room Decontamination System to its arsenal of new technology that helps disinfect environmental surfaces in patient rooms and in operating room suites.

21 Nov 2011

Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea

21 Nov 2011

UVA develops new and faster method to track superbugs

University of Virginia Health System researchers are the first in the world to develop a new and faster method to track major infection-causing "superbugs" - a major key in preventing the spread of deadly infections.

19 Nov 2011

First study to describe transporter system that bacteria use to ensure their survival

Bacteria responsible for middle ear infections, pink eye and sinusitis protect themselves from further immune attack by transporting molecules meant to destroy them away from their inner membrane target, according to a study from Nationwide Children's Hospital.

18 Nov 2011

InDevR introduces ampliPHOX system for microbiological analysis

InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.

18 Nov 2011

Biothera completes enrollment in Imprime PGG Phase II combination study on NSCLC

EBiothera's Phase II non-small cell lung cancer (NSCLC) clinical trial evaluating Imprime PGG administered in combination with cetuximab (Erbitux), carboplatin and paclitaxel has met its goal of 90 patients and is fully enrolled, the company announced today.

17 Nov 2011

The story of E. coli

It has been the cause of infamous international foodborne disease outbreaks and yet it is the most studied bacterium in science, an essential part of the human digestive tract, and a backbone of the biotech industry.

16 Nov 2011

Great Basin seeks FDA 510(k) approval for C. difficile molecular diagnostic test

Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its first molecular diagnostic test for Clostridium difficile (C. diff).

14 Nov 2011

Researchers retrace evolution of unusual bacterial infection

Researchers at Harvard Medical School and Children's Hospital Boston have retraced the evolution of an unusual bacterial infection as it spread among cystic fibrosis patients by sequencing scores of samples collected during the outbreak, since contained.

14 Nov 2011

Sleeping Beauty transposon system plays a vital role in investigating colorectal cancer pathway

A jumping gene with the fairy tale name "Sleeping Beauty" has helped to unlock vital clues for researchers investigating the genetics of colorectal cancer.

7 Nov 2011

Mouse anti-aging study generates expert commentary

Age related changes like wrinkles, muscle wasting and cataracts could be delayed in mice, say researchers in the US. They achieved the feat by removing old cells that had stopped dividing. These accumulate naturally with age. The scientists believe their findings could eventually “really have an impact” in the care of the elderly. Experts said the results were “fascinating”, but should be taken with a bit of caution.

6 Nov 2011

Common gut pathogen increases activity of SMO gene and causes colon tumors

Working with lab cultures and mice, Johns Hopkins scientists have found that a strain of the common gut pathogen Bacteroides fragilis causes colon inflammation and increases activity of a gene called spermine oxidase (SMO) in the intestine.

5 Nov 2011

Scientists identify distinct tobacco transporter for nicotine metabolism

A team of Virginia Tech and Purdue University scientists have identified a distinct transporter used by tobacco plant cells for nicotine metabolism. The research appears in the Oct. 17 online before print issue of the Proceedings of the National Academy of Sciences (PNAS) in the article, "A tobacco nicotine uptake permease effects alkaloid metabolism."

2 Nov 2011

Study finds multidrug-resistant Acinetobacter baumannii in 48% of infected patient rooms

Multidrug-resistant Acinetobacter baumannii (MDR-AB) was found in the environment of 48 percent of the rooms of patients colonized or infected with the pathogen, according to a new study published in the November issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

2 Nov 2011

First study to show how H. pylori toxin can spur apoptosis

Researchers report they have figured out how the cancer-causing bacterium Helicobacter pylori attacks a cell's energy infrastructure, sparking a series of events in the cell that ultimately lead it to self-destruct.

2 Nov 2011

Potential transmission of HBV, HCV and HIV infections in nail salons and barbershops

The risk of hepatitis transmission through non-single use instruments -- such as nail files, nail brushes, finger bowls, foot basins, buffers, razors, clippers, and scissors -- during nail salon and barbershop visits cannot be excluded, according to the results of a new report unveiled today at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC.

1 Nov 2011

Researcher's compound disables bacteria instead of killing them

After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?

29 Oct 2011

Researchers identify compound that inhibits viral replication

Broad-spectrum antibiotics, which are active against a whole range of bacterial pathogens, have been on the market for a long time. Comparably versatile drugs to treat viral diseases, on the other hand, have remained elusive. Using a new approach, research teams led by Dr. Albrecht von Brunn of LMU Munich and Professor Christian Drosten from the University of Bonn have identified a compound that inhibits the replication of several different viruses, including the highly aggressive SARS virus that is responsible for severe acute respiratory syndrome.

29 Oct 2011

Pathogen News and Research

Accelr8 expands development plan for BACcel rapid diagnostic test

Novel antibacterial protein could prevent or treat E. coli O157:H7-induced food-borne infections

Princeton acquires Tru-D SmartUVC Room Decontamination System to improve patient care

Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea

UVA develops new and faster method to track superbugs

First study to describe transporter system that bacteria use to ensure their survival

InDevR introduces ampliPHOX system for microbiological analysis

Biothera completes enrollment in Imprime PGG Phase II combination study on NSCLC

The story of E. coli

Great Basin seeks FDA 510(k) approval for C. difficile molecular diagnostic test

Researchers retrace evolution of unusual bacterial infection

Sleeping Beauty transposon system plays a vital role in investigating colorectal cancer pathway

Mouse anti-aging study generates expert commentary

Common gut pathogen increases activity of SMO gene and causes colon tumors

Scientists identify distinct tobacco transporter for nicotine metabolism

Study finds multidrug-resistant Acinetobacter baumannii in 48% of infected patient rooms

First study to show how H. pylori toxin can spur apoptosis

Potential transmission of HBV, HCV and HIV infections in nail salons and barbershops

Researcher's compound disables bacteria instead of killing them

Researchers identify compound that inhibits viral replication

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News